Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free HEMO Stock Alerts

Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History

Hemogenyx Pharmaceuticals logo
GBX 731 +31.00 (+4.43%)
As of 03:19 AM Eastern
Compare

Hemogenyx Pharmaceuticals Stock Price Performance

5 Day
Performance
+35.37%
1 Month
Performance
+40.58%
3 Month
Performance
-8.28%
Year-To-Date
Performance
+26.47%
1 Year
Performance
-38.64%
5 Year
Performance
+35,998.77%

HEMO Stock Chart for Tuesday, October, 6, 2026

30 Days 90 Days 1 Year

The Hemogenyx Pharmaceuticals (HEMO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 38.64%, with a year-to-date return of 26.47%. In the past month, the stock has increased 40.58%, reflecting recent market activity.

As of the latest close, Hemogenyx Pharmaceuticals traded at GBX 700 with a market cap of £47.60 million and volume of 46,949 shares. Five years ago, the stock traded at GBX 2.03, representing a 35,998.77% increase over that period. At the time, it had a market cap of £19.84 million and a volume of 10.76 million shares. View the advanced HEMO chart on TradingView.

Receive HEMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Hemogenyx Pharmaceuticals Stock Price History

Price Date
0 Results
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
10/05/2026GBX 650GBX 700
+7.69%		GBX 750GBX 65046,949 shs£47.60 million
10/02/2026GBX 540GBX 650
+20.37%		GBX 800GBX 51093,604 shs£44.20 million
10/01/2026GBX 459GBX 540
+17.65%		GBX 540GBX 460.5020,400 shs£36.72 million
09/30/2026GBX 472.50GBX 459
-2.86%		GBX 495GBX 4595,704 shs£31.21 million
09/29/2026GBX 478.50GBX 472.50
-1.25%		GBX 495GBX 4504,677 shs£32.13 million
09/28/2026GBX 474.50GBX 478.50
+0.84%		GBX 480GBX 444.1521,844 shs£32.54 million
09/25/2026GBX 480GBX 474.50
-1.15%		GBX 479.50GBX 451.504,564 shs£32.27 million
09/24/2026GBX 455GBX 480
+5.49%		GBX 480GBX 4406,344 shs£32.64 million
09/23/2026GBX 470GBX 455
-3.19%		GBX 468GBX 430.5028,128 shs£30.94 million
09/22/2026GBX 460GBX 470
+2.17%		GBX 470GBX 430.2013,789 shs£31.96 million
09/21/2026GBX 439GBX 460
+4.78%		GBX 472.80GBX 435.9611,752 shs£31.28 million
09/18/2026GBX 465GBX 439
-5.59%		GBX 479GBX 43947,388 shs£29.85 million
09/17/2026GBX 455GBX 465
+2.20%		GBX 479.50GBX 4506,923 shs£31.62 million
09/16/2026GBX 444.50GBX 455
+2.36%		GBX 480GBX 430.505,653 shs£30.94 million
09/15/2026GBX 453GBX 444.50
-1.88%		GBX 470GBX 430.5013,790 shs£30.23 million
09/14/2026GBX 437GBX 453
+3.66%		GBX 479.50GBX 43046,776 shs£30.80 million
09/11/2026GBX 448GBX 437
-2.46%		GBX 479.50GBX 431.8638,032 shs£29.72 million
09/10/2026GBX 490GBX 448
-8.57%		GBX 461.50GBX 43771,574 shs£30.46 million
09/09/2026GBX 475GBX 490
+3.16%		GBX 490GBX 442.2952,709 shs£33.32 million
09/08/2026GBX 515GBX 475
-7.77%		GBX 510GBX 46071,460 shs£32.30 million
09/07/2026GBX 520GBX 515
-0.96%		GBX 530GBX 481.5659,204 shs£35.02 million
Related Companies

This page (LON:HEMO) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners
They're not telling you how bad this could get
Valuations have reached levels seen only a handful of times in the past century, while debt concerns and tarif...
Parkview Capital Group | Sponsoredtc pixel
This smart glasses tech is bringing the screen to your eyes
Global AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...
The Tomorrow Investor | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
MAJOR BUY ALERT: Elon, Data Centers, Space
Stock picker Luke Lango recently toured Vegas and counted more than 60 new data centers under construction, ev...
InvestorPlace | Sponsoredtc pixel
I've seen this movie before (last time: 17,556%)
My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...
Crypto 101 Media | Sponsoredtc pixel
Analyst nicknamed “The Prophet” issues new warning for America
Whitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...
Stansberry Research | Sponsoredtc pixel